Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Verhoef, T.I."'
Autor:
Zhang, Y., de Boer, A., Verhoef, T.I., van der Meer, F.J.M., Le Cessie, S., Manolopoulos, V.G., Maitland‐van der Zee, A.H. *, Daly, A., Kamali, F., Redekop, K., Pirmohamed, M., Rosendaal, F.R., Wadelius, M.
Publikováno v:
In Journal of Thrombosis and Haemostasis March 2017 15(3):454-464
Autor:
VAN SCHIE, R.M.F., BABAJEFF, A.M.V., SCHALEKAMP, T., WESSELS, J.A.M., LE CESSIE, S., de BOER, A., VAN DER MEER, F.J.M., VAN MEEGEN, E., VERHOEF, T.I., ROSENDAAL, F.R., MAITLAND‐VAN DER ZEE, A.H. *
Publikováno v:
In Journal of Thrombosis and Haemostasis May 2012 10(5):767-772
Autor:
VERHOEF, T.I., REDEKOP, W.K., BUIKEMA, M.M., SCHALEKAMP, T., VAN DER MEER, F.J.M., LE CESSIE, S, WESSELS, J.A.M., VAN SCHIE, R.M.F., DE BOER, A., TEICHERT, M., VISSER, L.E., MAITLAND‐VAN DER ZEE, A.H. *
Publikováno v:
In Journal of Thrombosis and Haemostasis April 2012 10(4):606-614
Autor:
Baranova, E.V., Verhoef, T.I., Ragia, G., le Cessie, S., Asselbergs, F.W., de Boer, A., Manolopoulos, V.G., Maitland‐van der Zee, A.H. *, Barallon, R., Daly, A., Kamili, F., Redekop, K., Pirmohamed, M., Rosendaal, F.R., Wadelius, M.
Publikováno v:
In Journal of Thrombosis and Haemostasis March 2017 15(3):465-472
Autor:
Zhang, Y., Boer, A. de, Verhoef, T.I., Meer, F.J.M. van der, Cessie, S. le, Manolopoulos, V.G., Maitland-Van Der Zee, A.H.
Publikováno v:
Pharmacoepidemiology and Drug Safety, 25, 570-571
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c465f76826c49d8a69714a86d39d0ee2
https://hdl.handle.net/1887/112917
https://hdl.handle.net/1887/112917
Autor:
Schie, R.M.F. van, Wessels, J.A.M., Cessie, S. le, Boer, A. de, Schalekamp, T., Meer, F.J.M. van der, Verhoef, T.I., Meegen, E. van, Rosendaal, F.R., Maitland-van der Zee, A.H., EU-PACT Study Grp
Publikováno v:
European Heart Journal
European Heart Journal, 32(15), 1909-1917
European Heart Journal; Vol 32
European Heart Journal, 32(15), 1909-1917
European Heart Journal; Vol 32
Polymorphisms in CYP2C9 and VKORC1 influence patients' phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. To provide physicians with tools to estimate the patient's individual dose, we aimed to develop algorithms for PHE and ACE.In two Du
Autor:
Verhoef, T.I.
Coumarin derivatives such as acenocoumarol, phenprocoumon and warfarin are frequently used for the prevention of stroke and systemic embolism in patients with atrial fibrillation or for the treatment of venous thromboembolism. These oral anticoagulan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::b633841b63844967e5c9fee7546f4a3b
https://dspace.library.uu.nl/handle/1874/286212
https://dspace.library.uu.nl/handle/1874/286212
Autor:
Verhoef, T.I., Ragia, G., Boer, A. de, Barallon, R., Kolovou, G., Kolovou, V., Konstantinides, S., Cessie, S. le, Maltezos, E., Meer, F.J.M. van der, Redekop, W.K., Remkes, M., Rosendaal, F.R., Schie, R.M.F. van, Tavridou, A., Tziakas, D., Wadelius, M., Manolopoulos, V.G., Maitland-van der Zee, A.H., EU-PACT Grp
Publikováno v:
New England journal of medicine, 369(24), 2304-2312. Massachussetts Medical Society
New England Journal of Medicine, 369(24), 2304-2312. Massachussetts Medical Society
New England Journal of Medicine; Vol 369
New England Journal of Medicine, 369(24), 2304-2312
New England Journal of Medicine, 369(24), 2304-2312. Massachussetts Medical Society
New England Journal of Medicine; Vol 369
New England Journal of Medicine, 369(24), 2304-2312
BACKGROUND Observational evidence suggests that the use of a genotype-guided dosing algorithm may increase the effectiveness and safety of acenocoumarol and phenprocoumon therapy. METHODS We conducted two single-blind, randomized trials comparing a g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c4d096dc03eb49d448b91807ad8392
https://pure.amc.nl/en/publications/a-randomized-trial-of-genotypeguided-dosing-of-acenocoumarol-and-phenprocoumon(ed63579d-0a65-43fd-af76-ea9275385b2f).html
https://pure.amc.nl/en/publications/a-randomized-trial-of-genotypeguided-dosing-of-acenocoumarol-and-phenprocoumon(ed63579d-0a65-43fd-af76-ea9275385b2f).html
Publikováno v:
In Journal of Thrombosis and Haemostasis December 2012 10(12):2610-2612
Autor:
Verhoef, T.I., Zuurhout, M.J.L., Schie, R.M.F. van, Redekop, W.K., Meer, F.J.M. van der, Cessie, S. le, Schalekamp, T., Boer, A. de, Zee, A.H.M. van der
Publikováno v:
Pharmacoepidemiology and Drug Safety, 21, 187-187
British Journal of Clinical Pharmacology, 74(6), 1068-1069
British Journal of Clinical Pharmacology, 74(6), 1068-1069
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8d81d381bb2c100584f01377c06481b1
http://hdl.handle.net/1887/99210
http://hdl.handle.net/1887/99210